UiPath Inc. stocks have been trading up by 7.38 percent amid upbeat automation demand and strong AI-driven growth expectations.
Click Here for a Millionaire's POV on Trading PATH
SUBSCRIBE FOR ALERTSJOIN 50,000+ ACTIVE TRADERS
Key Takeaways For PATH Traders
- Q2 FY27 revenue climbed 13% year over year to about $410M, beating expectations, with ARR up 12% to $1.94B and PATH delivering positive GAAP and non-GAAP operating income.
- Management nudged FY27 revenue guidance to $1.789B–$1.794B and forecast ARR of $2.065B–$2.07B, reinforcing a mid-teens growth and profitability trajectory.
- Q3 outlook calls for $440M–$445M in revenue and ARR of $1.992B–$1.997B, signaling steady, if unspectacular, near-term expansion for UiPath.
- Citi launched coverage of PATH with a Buy and $23 target, while RBC, BMO, and Barclays all raised price targets after the beat-and-raise quarter.
- Leadership moves at UiPath, including promoting Hitesh Ramani to CFO and sharpening Ashim Gupta’s COO role, aim to tighten execution heading into the next phase of AI-driven automation growth.
Live Update At 12:34:26 EDT: On Monday, September 14, 2026 UiPath Inc. stock [NYSE: PATH] is trending up by 7.38%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
PATH has been on a wild ride. At the end of August, UiPath traded near $18.50, then spiked to an intraday high of $18.83 on 2026/09/03 before selling off hard. By 2026/09/11, PATH closed at $13.75 and then bounced to $14.77 on 2026/09/14. That’s a drawdown of roughly 20% from the pre-earnings highs, followed by a short-term relief move.
On the intraday chart, PATH shows a slow grind higher from around $14.00 in premarket to just under $14.80 midday. The tape is clean: higher lows, tight five‑minute candles, and very little sharp rejection. That kind of controlled staircase action usually means rotation from weak hands to stronger ones, not pure short‑covering chaos.
More Breaking News
- ZTG Stock Sees Explosive Volatility As Momentum Traders Pile In
- ALHC Stock Sinks As Legal And Cost Pressures Mount
- HBAN Stock Pulls Back As Profitability Stays Solid
- YFOR Stock Holds Support As Volatility Draws Active Traders
Under the hood, UiPath is throwing off real numbers. Revenue over the last year is about $1.61B with gross margin near 83%, and PATH sports positive operating income and free cash flow in the latest quarter. A price‑to‑sales ratio near 4.3 and P/E around 23 put UiPath well below the frothiest AI names, while a current ratio of 2.3 and minimal debt (total debt‑to‑equity roughly 0.04) give PATH breathing room. For traders, this is not a story of survival; it is a story of how fast the AI automation engine can scale.
Why Traders Are Watching PATH’s AI Execution
The fundamental backdrop for PATH has firmed up just as the stock pulled back. UiPath’s Q2 FY27 print came in ahead of guidance with revenue of about $410M, up 13% year over year, and ARR at $1.94B, up 12%. Both GAAP and non‑GAAP operating income turned positive, and gross margins stayed above 80%. For an AI‑and‑automation platform at this scale, pairing double‑digit growth with real profits is a big deal.
Management did not swing for the fences on guidance, but they did raise the bar. Full‑year FY27 revenue is now pegged at $1.789B–$1.794B, a modest bump above both prior guidance and Street expectations. ARR is projected at $2.065B–$2.07B. That message to PATH traders is simple: the pipeline is visible, growth in the mid‑teens looks durable, and profitability should expand from here.
Near term, UiPath guided Q3 revenue to $440M–$445M and ARR to just under $2.0B. Those numbers sit roughly in line with consensus, so PATH is not a “shock and awe” growth rocket for this quarter. Instead, it trades more like an execution story: if UiPath keeps hitting its steady targets, the multiple can creep higher.
Wall Street is starting to lean that way. Citi initiated PATH with a Buy and a $23 target, framing UiPath as the “control plane” for enterprise AI as companies struggle to move from pilots to scaled automation. RBC, BMO, and Barclays all raised price targets into the mid‑teens to high‑teens, though they stayed neutral on ratings, signaling respect for the story but a demand for more proof of sustained acceleration.
Strategically, UiPath is pushing hard beyond classic robotic process automation. New Maestro Case and Maestro Flow orchestration tools are designed to help enterprises stitch together AI agents, legacy systems, and human workflows. A global UiPath survey shows many large enterprises stuck in pilot mode due to data and governance headaches; the company is positioning PATH as the bridge that turns AI tests into real‑world deployments. The PLDT win in telecom, with measurable productivity and response‑time gains, gives traders a tangible proof point that this orchestration pitch is landing in demanding, data‑heavy environments.
Conclusion
For active traders, PATH now sits at an interesting crossroads. On one side, you have a stock that just absorbed a sharp post‑earnings selloff, dropping from the high‑teens toward the mid‑teens before stabilizing. On the other, you have UiPath delivering a beat‑and‑raise quarter, posting positive operating income, and nudging guidance higher for both revenue and ARR.
Leadership changes signal UiPath knows execution is everything from here. Long‑time finance hand Hitesh Ramani steps into the CFO seat, while Ashim Gupta focuses fully on COO duties and a seasoned IT operator, Yazdi Bagli, joins the board. For PATH traders, that looks like a setup aimed at tightening operational discipline just as the company leans into business orchestration and large‑enterprise AI rollouts.
The real swing factor is whether PATH can turn its “control plane for AI” narrative into faster ARR growth. If Maestro‑driven orchestration and marquee wins like PLDT scale across more verticals, the Street’s cautious neutrality may give way to more aggressive targets. Until then, the chart tells you PATH is a volatility‑rich name tied to every AI headline.
As Tim Sykes loves to remind traders, “The market doesn’t care about your opinion, it cares about price action and catalysts.” That’s why trade planning and psychology matter just as much as the fundamentals or the chart. As Tim Bohen, lead trainer with StocksToTrade says, “The best trades are the ones you can make without emotion. Plan it, then execute it as if it’s routine.”. UiPath is serving up both right now. Just remember this article is for educational and research purposes only, and any trading decisions around PATH require your own homework, risk management, and discipline.
This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.
Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.
Check out our quick startup guide for new traders!
- How to Read Stock Charts: A Guide for Beginners
- Trading Plan: 6 Steps to Create One
- How To Create a Stock Watchlist
Ready to build your watchlists? Check out these curated lists:
Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.